← Leaderboards
Shannon McCool
Rxbio, Inc.
$9,652,330
Attributed
$9,652,330
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2013–20$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,652,330 · 2
By mechanism
N01$9,652,330 · 2
Top collaborators
No co-investigators on record.
Most similar at Rxbio, Inc.
Same institution · by research overlap
- Wenlin Deng$1,025,784
- Veeresh Gududuru$97,162
- Samina Khan$297,087
Others in their field
Top investigators on “Irradiation”
- J. Mark Cline · Wake Forest University$49,621,390
- Walter John Curran · Thomas Jefferson University$26,641,549
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$26,572,036
- Samuel Strober · Stanford University$25,778,911
- Ehud Isacoff · University Of California Berkeley$23,946,000
- David Jonathan Brenner · Columbia University Health Sciences$22,934,756
Research focus
IrradiationGastrointestinalAdvanced DevelopmentContractsDoseNonhuman PrimateElementsEvaluationRadiation SyndromesAdvisory CommitteesLeukocytesCaringMeetingsAwardLeadMedicalAnimal ModelGranulocyteGranulocyte Colony-Stimulating FactorGrowth FactorAnimal Model DevelopmentSafetyRegimenRadiation Toxicity
Grant awards (7)
IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome.$1,524,658
N01 · FY2020 · AI · contact PI
IND-Enabling Development of Rx100 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome.$1,529,303
N01 · FY2019 · AI · contact PI
Development of Medical Countermeasures to Mitigate or Treat GI-ARS$396,356
N01 · FY2018 · AI · contact PI
Development of Medical Countermeasures to Mitigate or Treat GI-ARS$205,528
N01 · FY2017 · AI · contact PI
Development of Medical Countermeasures to Mitigate or Treat GI-ARS$1,998,223
N01 · FY2015 · AI · contact PI
Development of Medical Countermeasures to Mitigate or Treat GI-ARS$1,998,947
N01 · FY2014 · AI · contact PI
Development of Medical Countermeasures to Mitigate or Treat GI-ARS$1,999,315
N01 · FY2013 · AI · contact PI